期刊文献+

施救与科研双告捷:两次疫情中我国医学论文发表情况对比

Success both in rescue and scientific research:comparison of medical papers published by Chinese in two epidemics
原文传递
导出
摘要 面对百年不遇的新型冠状病毒肺炎(COVID⁃19)疫情,我国医务工作者在短短4个月内不仅成功地控制了疫情在我国大陆的蔓延,而且在COVID⁃19的科研方面也硕果累累。近4个月内,我国学者发表并被PubMed数据库收录的有关COVID⁃19英文文献共1033篇,是2003年全年发表论文数量的6.6倍;其中中国大陆作者发表文献的占比从2003年SARS流行期间的48.7%(76/156)上升至2020年近4个月发表文献的84.8%(876/1033)。论文发表时间也明显提前,中国的研究人员在COVID⁃19疫情出现不到1个月(2020年1月7日)就鉴定出导致这次疫情的新型冠状病毒,并向WHO报告,当月还发表了有关病毒基因序列、传播动力学和临床特征的论文。中国更加关注患者的用药安全,药学专业人员发表的英文和中文文献占比从2003年的0和0.2%(10/4023)上升至2020年1月至4月的2.3%(24/1032)和9.3%(215/2317)。中国不仅在疫情控制方面成为世界的榜样,而且在有关学术研究方面也做出了重要的贡献。 Facing the unprecedented epidemic situation of novel coronavirus pneumonia(COVID-19),medical workers in China have not only successfully controlled the spread of the epidemic in Chinese mainland in just 4 months,but also have made great achievements in scientific research on COVID-19.In the past 4 months,a total of 1033 English papers about COVID-19 written by Chinese scholars have been published and included in PubMed database,which is 6.6 times the number of articles published in 2003.The proportion of papers published by authors in Chinese mainland has increased from 48.7%(76/156)during the SARS epidemic in 2003 to 84.8%(876/1033)with 4 months in 2020.The papers were also published significantly earlier than before.Chinese researchers identified the novel coronavirus that caused the outbreak less than 1 month after the COVID-19 outbreak(on January 7,2020)and reported it to the WHO.They also published articles on the genetic sequence and transmission dynamics of the virus and clinical characteristics of COVID-19 patients in that month.China pays more attention to drug safety of patients.The proportion of English and Chinese literature published by pharmaceutical authors increased from 0 and 0.2%(10/4023)in 2003 to 2.3%(24/1032)and 9.3%(215/2317)from January to April in 2020,respectively.China has not only become a model for the world in epidemic control,but also made important contributions to the relevant academic research.
作者 蔡晧东 王育琴 Cai Haodong;Wang Yuqin(Adverse Drug Reactions Journal Agency,Beijing 100053,China;Liver Disease Center,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China;Department of Pharmacy,Xuanwu Hospital,Capital Medical University,Beijing 100053,China)
出处 《药物不良反应杂志》 CSCD 2020年第6期329-332,共4页 Adverse Drug Reactions Journal
关键词 冠状病毒感染 疾病暴发流行 基于文献的发现 文献计量学 中国 述评 Coronavirus infections Disease outbreaks Literature based discovery Bibliometrics China Editorial
  • 相关文献

参考文献6

二级参考文献23

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部